Selected research
Industry Research
Pet Tumor Screening Services Industry Research Report 2026
Market perspective
The global Pet Tumor Screening Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pet Tumor Screening Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pet Tumor Screening Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pet Tumor Screening Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pet Tumor Screening Services include PetDx, CYTOGEN, BioChain, Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., IDEXX Laboratories and Zoetis, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pet Tumor Screening Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pet Tumor Screening Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Tumor Screening Services Market by Company
PetDx
CYTOGEN
BioChain
Small Door
ANGLE
BioChain Institute Inc.
CANCAN DIAGNOSTICS.
IDEXX Laboratories
Zoetis
VCA Animal Hospitals
AniCura
Anicom Holdings
Tokyo Pet Medical Center
Qiming Pet Hospital
RuiPai Pet
IDK Animal Diagnostics
Beijing Pet Medical Center
Baili Pet Health
Pet Tumor Screening Services Segment by Type
Cut Biopsy
Needle Biopsy
Pet Tumor Screening Services Segment by Application
Pet Hospital
Clinic
Scientific Research Institutions
Pet Tumor Screening Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Tumor Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Tumor Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Tumor Screening Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pet Tumor Screening Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cut Biopsy
- Needle Biopsy
Applications
- Pet Hospital
- Clinic
- Scientific Research Institutions
Companies covered
- PetDx
- CYTOGEN
- BioChain
- Small Door
- ANGLE
- BioChain Institute Inc.
- CANCAN DIAGNOSTICS.
- IDEXX Laboratories
- Zoetis
- VCA Animal Hospitals
- AniCura
- Anicom Holdings
- Tokyo Pet Medical Center
- Qiming Pet Hospital
- RuiPai Pet
- IDK Animal Diagnostics
- Beijing Pet Medical Center
- Baili Pet Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pet Tumor Screening Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cut Biopsy
- 2.2.3 Needle Biopsy
- 2.3 Pet Tumor Screening Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pet Hospital
- 2.3.3 Clinic
- 2.3.4 Scientific Research Institutions
- 2.4 Assumptions and Limitations
3 Pet Tumor Screening Services Breakdown Data by Type
- 3.1 Global Pet Tumor Screening Services Historic Market Size by Type (2021-2026)
- 3.2 Global Pet Tumor Screening Services Forecasted Market Size by Type (2027-2032)
4 Pet Tumor Screening Services Breakdown Data by Application
- 4.1 Global Pet Tumor Screening Services Historic Market Size by Application (2021-2026)
- 4.2 Global Pet Tumor Screening Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pet Tumor Screening Services Market Perspective (2021-2032)
- 5.2 Global Pet Tumor Screening Services Growth Trends by Region
- 5.2.1 Global Pet Tumor Screening Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pet Tumor Screening Services Historic Market Size by Region (2021-2026)
- 5.2.3 Pet Tumor Screening Services Forecasted Market Size by Region (2027-2032)
- 5.3 Pet Tumor Screening Services Market Dynamics
- 5.3.1 Pet Tumor Screening Services Industry Trends
- 5.3.2 Pet Tumor Screening Services Market Drivers
- 5.3.3 Pet Tumor Screening Services Market Challenges
- 5.3.4 Pet Tumor Screening Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pet Tumor Screening Services Players by Revenue
- 6.1.1 Global Top Pet Tumor Screening Services Players by Revenue (2021-2026)
- 6.1.2 Global Pet Tumor Screening Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Pet Tumor Screening Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pet Tumor Screening Services Head Office and Area Served
- 6.4 Global Pet Tumor Screening Services Players, Product Type & Application
- 6.5 Global Pet Tumor Screening Services Manufacturers Established Date
- 6.6 Global Pet Tumor Screening Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pet Tumor Screening Services Market Size (2021-2032)
- 7.2 North America Pet Tumor Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pet Tumor Screening Services Market Size by Country (2021-2026)
- 7.4 North America Pet Tumor Screening Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pet Tumor Screening Services Market Size (2021-2032)
- 8.2 Europe Pet Tumor Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pet Tumor Screening Services Market Size by Country (2021-2026)
- 8.4 Europe Pet Tumor Screening Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pet Tumor Screening Services Market Size (2021-2032)
- 9.2 Asia-Pacific Pet Tumor Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pet Tumor Screening Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pet Tumor Screening Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pet Tumor Screening Services Market Size (2021-2032)
- 10.2 South America Pet Tumor Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pet Tumor Screening Services Market Size by Country (2021-2026)
- 10.4 South America Pet Tumor Screening Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pet Tumor Screening Services Market Size (2021-2032)
- 11.2 Middle East & Africa Pet Tumor Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pet Tumor Screening Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pet Tumor Screening Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 PetDx
- 12.1.1 PetDx Company Information
- 12.1.2 PetDx Business Overview
- 12.1.3 PetDx Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.1.4 PetDx Pet Tumor Screening Services Product Portfolio
- 12.1.5 PetDx Recent Developments
- 12.2 CYTOGEN
- 12.2.1 CYTOGEN Company Information
- 12.2.2 CYTOGEN Business Overview
- 12.2.3 CYTOGEN Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.2.4 CYTOGEN Pet Tumor Screening Services Product Portfolio
- 12.2.5 CYTOGEN Recent Developments
- 12.3 BioChain
- 12.3.1 BioChain Company Information
- 12.3.2 BioChain Business Overview
- 12.3.3 BioChain Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.3.4 BioChain Pet Tumor Screening Services Product Portfolio
- 12.3.5 BioChain Recent Developments
- 12.4 Small Door
- 12.4.1 Small Door Company Information
- 12.4.2 Small Door Business Overview
- 12.4.3 Small Door Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.4.4 Small Door Pet Tumor Screening Services Product Portfolio
- 12.4.5 Small Door Recent Developments
- 12.5 ANGLE
- 12.5.1 ANGLE Company Information
- 12.5.2 ANGLE Business Overview
- 12.5.3 ANGLE Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.5.4 ANGLE Pet Tumor Screening Services Product Portfolio
- 12.5.5 ANGLE Recent Developments
- 12.6 BioChain Institute Inc.
- 12.6.1 BioChain Institute Inc. Company Information
- 12.6.2 BioChain Institute Inc. Business Overview
- 12.6.3 BioChain Institute Inc. Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.6.4 BioChain Institute Inc. Pet Tumor Screening Services Product Portfolio
- 12.6.5 BioChain Institute Inc. Recent Developments
- 12.7 CANCAN DIAGNOSTICS.
- 12.7.1 CANCAN DIAGNOSTICS. Company Information
- 12.7.2 CANCAN DIAGNOSTICS. Business Overview
- 12.7.3 CANCAN DIAGNOSTICS. Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.7.4 CANCAN DIAGNOSTICS. Pet Tumor Screening Services Product Portfolio
- 12.7.5 CANCAN DIAGNOSTICS. Recent Developments
- 12.8 IDEXX Laboratories
- 12.8.1 IDEXX Laboratories Company Information
- 12.8.2 IDEXX Laboratories Business Overview
- 12.8.3 IDEXX Laboratories Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.8.4 IDEXX Laboratories Pet Tumor Screening Services Product Portfolio
- 12.8.5 IDEXX Laboratories Recent Developments
- 12.9 Zoetis
- 12.9.1 Zoetis Company Information
- 12.9.2 Zoetis Business Overview
- 12.9.3 Zoetis Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.9.4 Zoetis Pet Tumor Screening Services Product Portfolio
- 12.9.5 Zoetis Recent Developments
- 12.10 VCA Animal Hospitals
- 12.10.1 VCA Animal Hospitals Company Information
- 12.10.2 VCA Animal Hospitals Business Overview
- 12.10.3 VCA Animal Hospitals Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.10.4 VCA Animal Hospitals Pet Tumor Screening Services Product Portfolio
- 12.10.5 VCA Animal Hospitals Recent Developments
- 12.11 AniCura
- 12.11.1 AniCura Company Information
- 12.11.2 AniCura Business Overview
- 12.11.3 AniCura Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.11.4 AniCura Pet Tumor Screening Services Product Portfolio
- 12.11.5 AniCura Recent Developments
- 12.12 Anicom Holdings
- 12.12.1 Anicom Holdings Company Information
- 12.12.2 Anicom Holdings Business Overview
- 12.12.3 Anicom Holdings Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.12.4 Anicom Holdings Pet Tumor Screening Services Product Portfolio
- 12.12.5 Anicom Holdings Recent Developments
- 12.13 Tokyo Pet Medical Center
- 12.13.1 Tokyo Pet Medical Center Company Information
- 12.13.2 Tokyo Pet Medical Center Business Overview
- 12.13.3 Tokyo Pet Medical Center Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.13.4 Tokyo Pet Medical Center Pet Tumor Screening Services Product Portfolio
- 12.13.5 Tokyo Pet Medical Center Recent Developments
- 12.14 Qiming Pet Hospital
- 12.14.1 Qiming Pet Hospital Company Information
- 12.14.2 Qiming Pet Hospital Business Overview
- 12.14.3 Qiming Pet Hospital Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.14.4 Qiming Pet Hospital Pet Tumor Screening Services Product Portfolio
- 12.14.5 Qiming Pet Hospital Recent Developments
- 12.15 RuiPai Pet
- 12.15.1 RuiPai Pet Company Information
- 12.15.2 RuiPai Pet Business Overview
- 12.15.3 RuiPai Pet Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.15.4 RuiPai Pet Pet Tumor Screening Services Product Portfolio
- 12.15.5 RuiPai Pet Recent Developments
- 12.16 IDK Animal Diagnostics
- 12.16.1 IDK Animal Diagnostics Company Information
- 12.16.2 IDK Animal Diagnostics Business Overview
- 12.16.3 IDK Animal Diagnostics Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.16.4 IDK Animal Diagnostics Pet Tumor Screening Services Product Portfolio
- 12.16.5 IDK Animal Diagnostics Recent Developments
- 12.17 Beijing Pet Medical Center
- 12.17.1 Beijing Pet Medical Center Company Information
- 12.17.2 Beijing Pet Medical Center Business Overview
- 12.17.3 Beijing Pet Medical Center Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.17.4 Beijing Pet Medical Center Pet Tumor Screening Services Product Portfolio
- 12.17.5 Beijing Pet Medical Center Recent Developments
- 12.18 Baili Pet Health
- 12.18.1 Baili Pet Health Company Information
- 12.18.2 Baili Pet Health Business Overview
- 12.18.3 Baili Pet Health Revenue in Pet Tumor Screening Services Business (2021-2026)
- 12.18.4 Baili Pet Health Pet Tumor Screening Services Product Portfolio
- 12.18.5 Baili Pet Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst